Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma

Journal of Investigative Dermatology

Volumn 128, Issue 8, 2008, Pages 2024-2030

  North, Jeffrey P ^a,b   Kageshita, Toshiro ^c   Pinkel, Daniel ^a,d   Leboit, Philip E ^d,e   Bastian, Boris C ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MELANOMA; OCCULT CANCER; PRIORITY JOURNAL; SKIN MELANOMA; SKIN TUMOR; TUMOR CELL;

EID: 47349104747     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.41     Document Type: Article

References (14)

1. Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH (2000a) Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60:1968-73
2. Bastian BC, Leboit PE, Hamm H, Brocker EB, Pinkel D (1998) Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58:2170-5
3. Bastian BC, LeBoit PE, Pinkel D (2000b) Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 157:967-72
4. Bastian BC, Olshen AB, LeBoit PE, Pinkel D (2003) Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163:1765-70
5. Crowley NJ, Seigler HF (1992) Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg 127:1303-8
6. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-47
7. Dong XD, Tyler D, Johnson JL, DeMatos P, Seigler HF (2000) Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer 88:1063-71
8. Heenan PJ, Ghaznawie M (1999) The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg 52:209-13
9. Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS (1984) The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 200:759-63
10. MacCormack MA, Cohen LM, Rogers GS (2004) Local melanoma recurrence: a clarification of terminology. Dermatol Surg 30(12 Part 2):1533-8
11. Olsen G (1970) Some views on the treatment of melanomas of the skin. Arch Chir Neerl 22:79-90
12. Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS et al. (2002) Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res 62:3200-6
13. Treidman L, McNeer G (1963) Prognosis with local metastasis and recurrence in malignant melanoma. Ann N Y Acad Sci 100:123-30
14. Wildemore JK, Schuchter L, Mick R, Synnestvedt M, Elenitsas R, Bedrosian I et al. (2001) Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study. Ann Plast Surg 46:488-94